Michael Alvarado
Overview
Explore the profile of Michael Alvarado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahuron K, Shahid O, Sao P, Wu C, Haugh A, Huppert L, et al.
Cancer Res
. 2025 Mar;
PMID: 40042995
PD-1 pathway inhibitors have revolutionized cancer therapy. However, most patients do not durably benefit, highlighting the need for biomarkers to stratify patients as responders or non-responders. While CD8+ tumor infiltrating...
2.
Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, et al.
Am J Surg
. 2024 Nov;
241:116073.
PMID: 39571369
Background: The risks of postoperative complications in breast cancer patients vary by patient and tumor characteristics. Elevated BMI and invasive lobular carcinoma (ILC) increase risks of surgical complications and positive...
3.
Landers M, Newton F, Alvarado M, Bogduk N
Interv Pain Med
. 2024 Sep;
2(4):100279.
PMID: 39239217
No abstract available.
4.
Rothschild H, Clelland E, Mujir F, Record H, Wong J, Esserman L, et al.
Ann Surg Oncol
. 2023 Jul;
30(10):5999-6006.
PMID: 37464134
Background: Invasive lobular carcinoma (ILC) of the breast is known for high risk of late recurrence, yet some patients still recur within 5 years of diagnosis. Determining factors associated with...
5.
Mukhtar R, Chau H, Woriax H, Piltin M, Ahrendt G, Tchou J, et al.
Ann Surg
. 2023 Jun;
278(3):320-327.
PMID: 37325931
Neoadjuvant chemotherapy (NAC) increases rates of successful breast-conserving surgery (BCS) in patients with breast cancer. However, some studies suggest that BCS after NAC may confer an increased risk of locoregional...
6.
Barnes L, Foster R, Mukhtar R, Esserman L, Ewing C, Alvarado M, et al.
Plast Reconstr Surg Glob Open
. 2023 Feb;
11(1):e4767.
PMID: 36776594
Methods: We performed a retrospective chart review of all patients who underwent reduction mammoplasty followed by NSM at our institution between January 2014 and September 2020. Clinical and surgical characteristics...
7.
Vaidya J, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, et al.
Int J Radiat Oncol Biol Phys
. 2022 Dec;
115(1):256-259.
PMID: 36526392
No abstract available.
8.
Vaidya J, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, et al.
Int J Radiat Oncol Biol Phys
. 2022 Aug;
115(1):77-82.
PMID: 35998867
No abstract available.
9.
Clark A, Yau C, Wolf D, Petricoin E, J van t Veer L, Yee D, et al.
Nat Commun
. 2021 Nov;
12(1):6428.
PMID: 34741023
HER2-targeted therapy dramatically improves outcomes in early breast cancer. Here we report the results of two HER2-targeted combinations in the neoadjuvant I-SPY2 phase 2 adaptive platform trial for early breast...
10.
Hewitt K, Miller P, Piper M, Prionas N, Son J, Alvarado M, et al.
Am J Surg
. 2021 Jun;
223(4):699-704.
PMID: 34148670
Background: Surgical treatment of invasive lobular carcinoma (ILC) is challenging due to its diffuse growth pattern, and the positive margin rate after mastectomy is poorly described. Methods: We retrospectively determined...